Synergistic Melanoma Treatment System

A novel system integrating dapansutrile administration with AI-powered tumor monitoring, IoT-enabled data transmission, blockchain-based data storage, and nanomaterial-based delivery to provide personalized and effective melanoma treatment.

The original patent disclosed methods for treating melanoma using dapansutrile. However, these methods had limitations in terms of personalized treatment planning, real-time monitoring, and secure data storage. The new inventive concept addresses these limitations by integrating distinct technologies to create a more powerful system.

The system comprises a dapansutrile administration module, an AI-powered tumor monitoring module, and a blockchain-based data storage module. The AI-powered tumor monitoring module analyzes tumor size and response to dapansutrile treatment and provides personalized treatment recommendations. The system can also include a wearable device with a dapansutrile sensor, an IoT-enabled data transmission module, and a user interface. Additionally, a blockchain-based platform can be used to track melanoma treatment outcomes, and a nanomaterial-based delivery system can be employed to target dapansutrile delivery to the tumor site.

The new claims introduce the synergistic combination of dapansutrile administration with AI, IoT, blockchain, and nanomaterial-based technologies, which is not obvious from the original patent. The integration of these distinct technologies provides a novel and non-obvious solution for personalized melanoma treatment.

Alternative embodiments of the system could include using different AI algorithms, incorporating additional sensors in the wearable device, or employing different nanomaterials for targeted delivery. Variations could also include using the system for treating other types of cancer or integrating with other medical devices.

The Synergistic Melanoma Treatment System has significant commercial potential in the oncology market, particularly in the areas of personalized medicine and cancer treatment. The system's ability to provide real-time monitoring and personalized treatment recommendations could lead to improved treatment outcomes and increased patient satisfaction.